These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 24638046

  • 1. Adherence to antidepressant combinations and monotherapy for major depressive disorder: a CO-MED report of measurement-based care.
    Warden D, Trivedi MH, Carmody T, Toups M, Zisook S, Lesser I, Myers A, Kurian KR, Morris D, Rush AJ.
    J Psychiatr Pract; 2014 Mar; 20(2):118-32. PubMed ID: 24638046
    [Abstract] [Full Text] [Related]

  • 2. Does early-onset chronic or recurrent major depression impact outcomes with antidepressant medications? A CO-MED trial report.
    Sung SC, Wisniewski SR, Balasubramani GK, Zisook S, Kurian B, Warden D, Trivedi MH, Rush AJ, CO-MED Study Team.
    Psychol Med; 2013 May; 43(5):945-60. PubMed ID: 23228340
    [Abstract] [Full Text] [Related]

  • 3. Effect of antidepressant medication treatment on suicidal ideation and behavior in a randomized trial: an exploratory report from the Combining Medications to Enhance Depression Outcomes Study.
    Zisook S, Lesser IM, Lebowitz B, Rush AJ, Kallenberg G, Wisniewski SR, Nierenberg AA, Fava M, Luther JF, Morris DW, Trivedi MH.
    J Clin Psychiatry; 2011 Oct; 72(10):1322-32. PubMed ID: 22075098
    [Abstract] [Full Text] [Related]

  • 4. The impact of chronic depression on acute and long-term outcomes in a randomized trial comparing selective serotonin reuptake inhibitor monotherapy versus each of 2 different antidepressant medication combinations.
    Sung SC, Haley CL, Wisniewski SR, Fava M, Nierenberg AA, Warden D, Morris DW, Kurian BT, Trivedi MH, Rush AJ, CO-MED Study Team.
    J Clin Psychiatry; 2012 Jul; 73(7):967-76. PubMed ID: 22687487
    [Abstract] [Full Text] [Related]

  • 5. Pre-treatment insomnia as a predictor of single and combination antidepressant outcomes: a CO-MED report.
    Sung SC, Wisniewski SR, Luther JF, Trivedi MH, Rush AJ, COMED Study Team.
    J Affect Disord; 2015 Mar 15; 174():157-64. PubMed ID: 25497473
    [Abstract] [Full Text] [Related]

  • 6. Treatment adherence and persistence with duloxetine, venlafaxine XR, and escitalopram among patients with major depressive disorder and chronic pain-related diseases.
    Wang J, Liu X, Mullins CD.
    Curr Med Res Opin; 2011 Jul 15; 27(7):1303-13. PubMed ID: 21561393
    [Abstract] [Full Text] [Related]

  • 7. Combination of antidepressant medications from treatment initiation for major depressive disorder: a double-blind randomized study.
    Blier P, Ward HE, Tremblay P, Laberge L, Hébert C, Bergeron R.
    Am J Psychiatry; 2010 Mar 15; 167(3):281-8. PubMed ID: 20008946
    [Abstract] [Full Text] [Related]

  • 8. Baseline depression severity as a predictor of single and combination antidepressant treatment outcome: results from the CO-MED trial.
    Friedman ES, Davis LL, Zisook S, Wisniewski SR, Trivedi MH, Fava M, Rush AJ, CO-MED Study Team.
    Eur Neuropsychopharmacol; 2012 Mar 15; 22(3):183-99. PubMed ID: 21920711
    [Abstract] [Full Text] [Related]

  • 9. Randomized comparison of selective serotonin reuptake inhibitor (escitalopram) monotherapy and antidepressant combination pharmacotherapy for major depressive disorder with melancholic features: a CO-MED report.
    Bobo WV, Chen H, Trivedi MH, Stewart JW, Nierenberg AA, Fava M, Kurian BT, Warden D, Morris DW, Luther JF, Husain MM, Cook IA, Lesser IM, Kornstein SG, Wisniewski SR, Rush AJ, Shelton RC.
    J Affect Disord; 2011 Oct 15; 133(3):467-76. PubMed ID: 21601287
    [Abstract] [Full Text] [Related]

  • 10. Effect of concurrent substance use disorder on the effectiveness of single and combination antidepressant medications for the treatment of major depression: an exploratory analysis of a single-blind randomized trial.
    Davis LL, Pilkinton P, Wisniewski SR, Trivedi MH, Gaynes BN, Howland RH, Zisook S, Balasubramani GK, Fava M, Rush AJ.
    Depress Anxiety; 2012 Feb 15; 29(2):111-22. PubMed ID: 22495941
    [Abstract] [Full Text] [Related]

  • 11. Combining medications to enhance depression outcomes (CO-MED): acute and long-term outcomes of a single-blind randomized study.
    Rush AJ, Trivedi MH, Stewart JW, Nierenberg AA, Fava M, Kurian BT, Warden D, Morris DW, Luther JF, Husain MM, Cook IA, Shelton RC, Lesser IM, Kornstein SG, Wisniewski SR.
    Am J Psychiatry; 2011 Jul 15; 168(7):689-701. PubMed ID: 21536692
    [Abstract] [Full Text] [Related]

  • 12. Depression treatment in patients with general medical conditions: results from the CO-MED trial.
    Morris DW, Budhwar N, Husain M, Wisniewski SR, Kurian BT, Luther JF, Kerber K, Rush AJ, Trivedi MH.
    Ann Fam Med; 2012 Jul 15; 10(1):23-33. PubMed ID: 22230827
    [Abstract] [Full Text] [Related]

  • 13. Validating pre-treatment body mass index as moderator of antidepressant treatment outcomes: Findings from CO-MED trial.
    Jha MK, Wakhlu S, Dronamraju N, Minhajuddin A, Greer TL, Trivedi MH.
    J Affect Disord; 2018 Jul 15; 234():34-37. PubMed ID: 29522941
    [Abstract] [Full Text] [Related]

  • 14. Do baseline sub-threshold hypomanic symptoms affect acute-phase antidepressant outcome in outpatients with major depressive disorder? Preliminary findings from the randomized CO-MED trial.
    Jha MK, Malchow AL, Grannemann BD, Rush AJ, Trivedi MH.
    Neuropsychopharmacology; 2018 Oct 15; 43(11):2197-2203. PubMed ID: 30135556
    [Abstract] [Full Text] [Related]

  • 15. Tranylcypromine versus venlafaxine plus mirtazapine following three failed antidepressant medication trials for depression: a STAR*D report.
    McGrath PJ, Stewart JW, Fava M, Trivedi MH, Wisniewski SR, Nierenberg AA, Thase ME, Davis L, Biggs MM, Shores-Wilson K, Luther JF, Niederehe G, Warden D, Rush AJ.
    Am J Psychiatry; 2006 Sep 15; 163(9):1531-41; quiz 1666. PubMed ID: 16946177
    [Abstract] [Full Text] [Related]

  • 16. Eight-week, placebo-controlled, double-blind comparison of the antidepressant efficacy and tolerability of bupropion XR and venlafaxine XR.
    Hewett K, Chrzanowski W, Schmitz M, Savela A, Milanova V, Gee M, Krishen A, Millen L, Leary MO, Modell J.
    J Psychopharmacol; 2009 Jul 15; 23(5):531-8. PubMed ID: 18635695
    [Abstract] [Full Text] [Related]

  • 17. Combination antidepressant therapy for major depressive disorder: speed and probability of remission.
    Stewart JW, McGrath PJ, Blondeau C, Deliyannides DA, Hellerstein D, Norris S, Amat J, Pilowsky DJ, Tessier P, Laberge L, O'Shea D, Chen Y, Withers A, Bergeron R, Blier P.
    J Psychiatr Res; 2014 May 15; 52():7-14. PubMed ID: 24485847
    [Abstract] [Full Text] [Related]

  • 18. Reevaluating the Efficacy and Predictability of Antidepressant Treatments: A Symptom Clustering Approach.
    Chekroud AM, Gueorguieva R, Krumholz HM, Trivedi MH, Krystal JH, McCarthy G.
    JAMA Psychiatry; 2017 Apr 01; 74(4):370-378. PubMed ID: 28241180
    [Abstract] [Full Text] [Related]

  • 19. A comparison of mirtazapine and nortriptyline following two consecutive failed medication treatments for depressed outpatients: a STAR*D report.
    Fava M, Rush AJ, Wisniewski SR, Nierenberg AA, Alpert JE, McGrath PJ, Thase ME, Warden D, Biggs M, Luther JF, Niederehe G, Ritz L, Trivedi MH.
    Am J Psychiatry; 2006 Jul 01; 163(7):1161-72. PubMed ID: 16816220
    [Abstract] [Full Text] [Related]

  • 20. Interleukin 17 selectively predicts better outcomes with bupropion-SSRI combination: Novel T cell biomarker for antidepressant medication selection.
    Jha MK, Minhajuddin A, Gadad BS, Greer TL, Mayes TL, Trivedi MH.
    Brain Behav Immun; 2017 Nov 01; 66():103-110. PubMed ID: 28698115
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.